Role of HMGB1 in apoptosis-mediated sepsis lethality
暂无分享,去创建一个
K. Tracey | Huan Yang | Haichao Wang | M. Ochani | C. Czura | B. Sherry | S. Qin | Renqi Yuan | Hui-hui Li | K. Ochani | M. Rosas-Ballina | J. Huston | E. Miller | Xinchun Lin | Anjali Kumar | G. Larosa | W. Newman | M. Rosas‐Ballina | R. Yuan | Huan Yang
[1] R. Donato,et al. The Amphoterin (HMGB1)/Receptor for Advanced Glycation End Products (RAGE) Pair Modulates Myoblast Proliferation, Apoptosis, Adhesiveness, Migration, and Invasiveness , 2006, Journal of Biological Chemistry.
[2] S. Joos,et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas , 2005, Gut.
[3] C. Chung,et al. Leukocyte apoptosis and its significance in sepsis and shock , 2005, Journal of leukocyte biology.
[4] K. Tracey,et al. The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.
[5] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[6] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[7] K. Tracey. Fatal Sequence: The Killer Within , 2005 .
[8] M. Lotze,et al. Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death , 2005, Journal of immunotherapy.
[9] K. Tracey,et al. Recombinant HMGB1 with cytokine-stimulating activity. , 2004, Journal of immunological methods.
[10] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Stefan Joos,et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.
[13] M. Yamakuchi,et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.
[14] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[15] Jun Yu Li,et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. , 2002, Arthritis and rheumatism.
[16] K. Tracey,et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.
[17] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[18] Derek C. Angus,et al. Epidemiology of sepsis: An update , 2001, Critical care medicine.
[19] R. Hotchkiss,et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.
[20] P. Vandenabeele,et al. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. , 1999, Journal of immunology.
[21] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[22] I. Chaudry,et al. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. , 1996, The Journal of surgical research.
[23] K. Tracey,et al. HMGB1 in the immunology of sepsis (not septic shock) and arthritis. , 2004, Advances in immunology.